Trial Profile
Phase I trial of Vaxart's seasonal influenza tablet vaccine
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 13 Jan 2015
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Adverse reactions
- Sponsors Vaxart
- 13 Jan 2015 Planned initiation date changed to 1 Mar 2015.
- 13 Jan 2015 New trial record
- 08 Jan 2015 Vaxart has received finance to fund this follow-on phase I trial, according to a company media release.